Login / Signup

The role of glucagon in the possible mechanism of cardiovascular mortality reduction in type 2 diabetes patients.

Marko SkelinEugen JavorMarko LucijanićTomo LucijanićLejsa JakupovićDario Rahelić
Published in: International journal of clinical practice (2018)
This hypothesis throws new light upon possible mechanisms of reduction in mortality in T2D patients.
Keyphrases
  • end stage renal disease
  • type diabetes
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • peritoneal dialysis
  • prognostic factors
  • coronary artery disease
  • skeletal muscle